Bellevue Group AG
Q2 2021 13F-HR Holdings
Net value change ($000)
+792,764
(8.4%)
New positions
12
Sold out positions
15
Turnover %
2.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MRNA | 229,427 | 62.4% |
| VRTX | 53,725 | 18.2% |
| TNDM | 52,864 | 113.6% |
| FATE | 44,669 | 24.5% |
| IQV | 42,640 | 12252.9% |
| REGN | 42,077 | 248.4% |
| ELV | 39,516 | 28.6% |
| ADPT | 39,322 | NEW |
| CRSP | 37,313 | 31.3% |
| ARVN | 35,355 | 25.8% |
Top Reduces (Value $000, Stocks/ETFs)
| ALXN | -197,491 | -98.7% |
| CI | -47,473 | -43.8% |
| SRRK | -41,561 | -38.5% |
| DVA | -39,616 | -100.0% |
| BMY | -33,850 | -25.7% |
| Molecular Templates, Inc. | -27,533 | -26.8% |
| PODD | -24,863 | -21.9% |
| NBIX | -24,762 | -7.8% |
| HALO | -24,556 | -19.6% |
| Nuance Communications, Inc. | -20,462 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
39
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|